Swapnil Ballal (He/Him)
Vice President, Manufactuing
Entos Pharmaceuticals
Swapnil Ballal, a seasoned biopharmaceutical professional with over 29 years of global experience, is a recognized leader in GMP production, quality assurance, and compliance. He is Vice President of Manufacturing at Entos Pharmaceuticals, Canada.
He has contributed extensively to the pharmaceutical and biotechnology sectors, spearheading projects that include setting up state-of-the-art manufacturing facilities and ensuring regulatory compliance with global standards.
Among his notable achievements, Swapnil has successfully directed quality initiatives that resulted in GMP approvals from US FDA, EU, and other regulatory bodies. As a speaker, he combines technical expertise with practical insights, making complex regulatory and manufacturing concepts accessible to diverse audiences.
Swapnil has a history of active engagement with ISPE, serving as a contributor to key industry guides such as the ISPE Baseline Guide for Biopharmaceutical Manufacturing Facilities (2nd Edition) and the ISPE Good Practice Guide on Single-Use Technology. His leadership in the Disposables (Single-Use) Community of Practice and his presentations at ISPE and other international forums demonstrate his commitment to advancing pharmaceutical engineering practices.